NCT04712747

Brief Summary

The eye has long been recognized as a window to pathological processes occurring in the brain. By imaging the vascular system of the retina scientific understanding and clinical practice have been improved for a wide range of pathologies from diabetes to stroke and dementia. Adaptive optics (AO) reveals retinal details that remain invisible with other current imaging techniques. Indeed, vessels can be perfectly visualized, making it possible to detect wall irregularities, accurately measure their different structures and monitor their evolution under treatment if necessary. In AO, studies on retinal vessels involve the calculation of wall thickness (WT), outer diameter (OD), inner diameter (ID), wall cross-sectional area (WCSA) and wall to lumen ratio (WLR). An increase in WLR \> 0.31 is characteristic of hypertensive microangiopathy and predictive of cardiovascular and brain damage. This accurate assessment of microvascular structure may even be required in the near future in all patients with arterial hypertension. For vessels \> 300 microns in diameter, the increase in vessel wall thickness occurs without changing the ID, a process known as external hypertrophic remodeling. For small arteries \< 300 microns, remodeling occurs differently. The total volume of the vessel wall remains constant, but the OD and ID each decrease, a process known as inward eutrophic remodeling. The objective of this study is to describe the parameters measured in AO in patients in the acute phase of a stroke and then at 3 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 15, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

January 25, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2025

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

4 years

First QC Date

January 14, 2021

Last Update Submit

December 3, 2025

Conditions

Keywords

Adaptive optics

Outcome Measures

Primary Outcomes (3)

  • Wall thickness (WT) in adaptive optics

    Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls

    At the inclusion visit (less than 10 days after the stroke for the patients with stroke)

  • Wall cross-sectional area (WCSA) in adaptive optics

    Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls

    At the inclusion visit (less than 10 days after the stroke for the patients with stroke)

  • Wall to lumen ratio (WLR) in adaptive optics

    Comparison between groups : hemorrhagic strokes, ischemic strokes, controls

    At the inclusion visit (less than 10 days after the stroke for the patients with stroke)

Study Arms (2)

Cases - patients with stroke

Ophthalmological examinations : At the inclusion visit and 3 months after their stroke Blood pressure measurement at rest : At the inclusion visit

Procedure: Ophthalmological examinationsProcedure: Blood pressure measurement at rest

Controls - Individuals with no history of stroke

Ophthalmological examinations : At the inclusion visit Blood pressure measurement at rest : At the inclusion visit

Procedure: Ophthalmological examinationsProcedure: Blood pressure measurement at rest

Interventions

* OCT (Optical Coherence Tomography): posterior pole OCT B scan , optic nerve and posterior pole OCT Angiography * Adaptive optics (AO) : Image acquisition on the vessels at the exit of the optic nerve before the first upper temporal bifurcation OD or OG and evaluation of the photoreceptor mosaic. Adaptive optics may require dilatation of the pupil with a drop of tropicamide in the eye examined a few minutes before the examination. * Color retinophotography * Measurement of intraocular pressure Patients with stroke : At the inclusion visit and 3 months after their stroke Control group : At the inclusion visit.

Cases - patients with strokeControls - Individuals with no history of stroke

At the inclusion visit

Cases - patients with strokeControls - Individuals with no history of stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inpatients with confirmed stroke for less than 10 days and controls (Individuals presenting at the Rothschild Foundation Hospital with no history of stroke)

You may qualify if:

  • For the patients with stroke: Inpatients with confirmed stroke (clinical and imaging) for less than 10 days
  • For the controls: Individuals presenting at the Rothschild Foundation Hospital with no history of stroke who are matched to cases already included in the matching criteria: Age ± 5 years, Gender, high blood pressure (no history, untreated, treated) Diabetes (Yes, No), Body Mass Index (BMI \< 25, 25 ≥ BMI \< 30, BMI ≥ 30)

You may not qualify if:

  • Pregnant or breastfeeding woman
  • Insufficient state of consciousness or physical condition to perform the adaptive optics examination
  • For the patients with stroke: Hemorrhagic post-traumatic hematoma stroke type, or symptomatic stroke of a brain tumour or an arteriovenous malformation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Fondation A. de Rothschuld

Paris, 75019, France

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Martine MAUGET FAYSSE, MD

    Hôpital Fondation A. de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2021

First Posted

January 15, 2021

Study Start

January 25, 2021

Primary Completion

January 14, 2025

Study Completion

January 14, 2025

Last Updated

December 10, 2025

Record last verified: 2025-12

Locations